Adial Pharmaceuticals, Inc. Related Party Transaction, Amounts of Transaction
Adial Pharmaceuticals, Inc. (ADIL) reported Related Party Transaction, Amounts of Transaction of $32.01 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Notes
us-gaap:RelatedPartyTransactionAmountsOfTransaction · last filed 2024-04-01
- Adial Pharmaceuticals, Inc. related party transaction, amounts of transaction for fiscal 2023 was $32.01K.
- Adial Pharmaceuticals, Inc. related party transaction, amounts of transaction for fiscal 2022 was $0.00.
| Period end | Related Party Transaction, Amounts of Transaction 12 month |
|---|---|
| 2023-12-31 | $32.01K 10-K · filed 2024-04-01 |
| 2022-12-31 | $0.00 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |